FDA NDC Directory · JSON-LD · Markdown
NDC 69097-508 · HUMAN PRESCRIPTION DRUG · FOR SUSPENSION
| Labeler / Manufacturer | Cipla USA Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA217714 |
| Dosage form / route | FOR SUSPENSION · ORAL |
| Active ingredients | ESOMEPRAZOLE MAGNESIUM DIHYDRATE (5 mg/1) |
| Marketing started | 20250107 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).